First Choice Healthcare Solutions, Inc. (FCHS): Gross Profit
$7.3K
Year ended 2025-12-31
-81.0%
3-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.3K | n/a | 2026-03-11, From 2025-01-01 |
| No annual figure between 2023-12-31 and 2025-12-31. | |||
| 2023-12-31 | $30.0K | -97.2% | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $1.07M | n/a | 2024-05-13, From 2022-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| First Choice Healthcare Solutions, Inc. (FCHS) | 2025-12-31 | $7.3K | n/a |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $1.09M | -15.8% |
| Aclarion, Inc. (ACON) | 2025-12-31 | $6.8K | n/m |
| YD Bio Ltd (YDES) | 2025-12-31 | $167.4K | +7.8% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $5.06M | -44.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $38.80M | +17.2% |
| Sera Prognostics, Inc. (SERA) | 2025-12-31 | -$83.0K | n/m |
| Personalis, Inc. (PSNL) | 2025-12-31 | $15.78M | -41.2% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $273.20M | +0.5% |
Compare FCHS, BGLC, ACON, YDES side by side · Screen every company in Services-Medical Laboratories ↗